Long-lasting clinical efficacy of allergen specific immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 4, 2002, Pages 275-276

  Passalacqua, G ^a   Canonica, G W ^a  

^a DIMI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD4 ANTIGEN; VACCINE;

ALLERGY; ASTHMA; DISEASE COURSE; EDITORIAL; IMMUNOTHERAPY; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RHINITIS; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; VACCINATION;

DESENSITIZATION, IMMUNOLOGIC; HUMANS; RESPIRATORY HYPERSENSITIVITY; TIME; TREATMENT OUTCOME;

EID: 0036215564     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.03264.x     Document Type: Editorial

References (17)

1. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
2. WHO Position Paper. Allergen immunotherapy
3. WHO Position Paper. Allergic Rhinitis and its Impact on Asthma (ARIA)
4. A study of the natural history of bronchial asthma in children
5. +) cells accompany inhibition of allergen induced late skin responses following successful grass pollen immunotherapy
6. Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Ph1 p 1, a major grass pollen allergen
7. Immunotherapy ad a preventive treatment
8. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitisations in children
9. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study
10. Prevention of new sensitizations in monosensitized subjects, submitted to specific immunotherapy or not. A retrospective study
11. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis
12. Persistence of efficacy after a brief course of polymerized ragweed allergen: A controlled study
13. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy
14. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of efficacy of immunotherapy after its cessation
15. Long term allergoid immunotherapy to Parietaria: Clinical and immunological effects in a double blind trial
16. Long term clinical efficacy of grass pollen immunotherapy
17. Long-term efficacy of preseasonal grass pollen immunotherapy in children